Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Iovance Biotherapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 273
- +37 vs. Q4 2023
- Shares held
- 217.2M
- +9.90M (+4.8%) vs. Q4 2023
- Total value
- $3.22B
- +$1.53B (+90.9%) vs. Q4 2023
- New holders
- 70
- 90 more added
- Sold out
- 33
- 83 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CM Management, LLC | 250,000 | $3.71M | 3.11% | 00.0% | Unchanged |
| Barclays PLC | 255,353 | $3.78M | 0.00% | −580,822−69.5% | Reduced |
| Stifel Financial Corp | 258,295 | $3.83M | 0.00% | −50,459−16.3% | Reduced |
| Nomura Asset Management Co Ltd | 278,135 | $4.12M | 0.01% | +278,135 | New |
| HRT Financial LP | 296,174 | $4.39M | 0.03% | +1,411+0.5% | Added |
| PFM Health Sciences, LP | 310,754 | $4.61M | 0.23% | +310,754 | New |
| Alliancebernstein L.P. | 315,440 | $4.67M | 0.00% | +62,550+24.7% | Added |
| Panagora Asset Management Inc | 323,666 | $4.80M | 0.03% | −22,524−6.5% | Reduced |
| Schroder Investment Management Group | 330,783 | $4.90M | 0.01% | +6,047+1.9% | Added |
| SEI Investments Co | 333,148 | $4.94M | 0.01% | +84,382+33.9% | Added |
| American Century Companies Inc | 338,516 | $5.02M | 0.00% | +5,380+1.6% | Added |
| Manufacturers Life Insurance Company, The | 358,988 | $5.32M | 0.00% | +94,017+35.5% | Added |
| Wells Fargo & Company | 367,787 | $5.45M | 0.00% | +20,059+5.8% | Added |
| Swiss National Bank | 378,956 | $5.62M | 0.00% | −60,500−13.8% | Reduced |
| Rhumbline Advisers | 391,550 | $5.80M | 0.01% | +23,094+6.3% | Added |
| Hennion & Walsh Asset Management, Inc. | 407,429 | $6.04M | 0.32% | +121,395+42.4% | Added |
| Group One Trading, L.P. | 488,038 | $7.23M | 0.26% | −88,264−15.3% | Reduced |
| Tang Capital Management LLC | 500,000 | $7.41M | 0.77% | −500,000−50.0% | Reduced |
| TD Asset Management Inc | 505,278 | $7.49M | 0.01% | +247,818+96.3% | Added |
| Eagle Asset Management Inc | 551,018 | $7.82M | 0.04% | +100,562+22.3% | Added |
| Citigroup Inc | 539,895 | $8.00M | 0.01% | −214,013−28.4% | Reduced |
| Rafferty Asset Management, LLC | 584,111 | $8.66M | 0.03% | −663,404−53.2% | Reduced |
| Driehaus Capital Management LLC | 642,761 | $9.53M | 0.09% | +642,761 | New |
| Braidwell LP | 660,022 | $9.78M | 0.32% | +660,022 | New |
| QVT Financial LP | 678,564 | $10.1M | 0.94% | 00.0% | Unchanged |
| Banque Pictet & Cie SA | 689,356 | $10.2M | 0.11% | −88,682−11.4% | Reduced |
| UBS Group AG | 690,880 | $10.2M | 0.00% | −166,428−19.4% | Reduced |
| Deutsche Bank AG | 723,666 | $10.7M | 0.00% | −1,191,746−62.2% | Reduced |
| Boxer Capital, LLC | 750,000 | $11.1M | 0.55% | −650,000−46.4% | Reduced |
| Bank of New York Mellon Corp | 834,224 | $12.4M | 0.00% | −15,981−1.9% | Reduced |
| Opaleye Management Inc. | 897,000 | $13.3M | 2.90% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 955,000 | $14.2M | 1.34% | −161,818−14.5% | Reduced |
| Jane Street Group, LLC | 1,021,067 | $15.1M | 0.02% | +498,506+95.4% | Added |
| Candriam Luxembourg S.C.A. | 1,059,142 | $15.7M | 0.10% | −668,680−38.7% | Reduced |
| C WorldWide Group Holding A/S | 1,060,000 | $15.7M | 0.18% | −300,000−22.1% | Reduced |
| Norges Bank | 1,091,987 | $16.2M | 0.00% | −28,470−2.5% | Reduced |
| Citadel Advisors LLC | 1,110,997 | $16.5M | 0.02% | +824,963+288.4% | Added |
| New York State Common Retirement Fund | 1,164,734 | $17.3M | 0.02% | +142,910+14.0% | Added |
| Balyasny Asset Management LLC | 1,200,864 | $17.8M | 0.05% | −2,725,295−69.4% | Reduced |
| 683 Capital Management, LLC | 1,225,000 | $18.2M | 1.85% | −525,000−30.0% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,313,339 | $19.5M | 0.01% | +1,313,339 | New |
| Long Focus Capital Management, LLC | 1,400,312 | $20.8M | 2.40% | −735,209−34.4% | Reduced |
| Woodline Partners LP | 1,482,859 | $22.0M | 0.20% | −121,847−7.6% | Reduced |
| Bank of America Corp | 1,532,304 | $22.7M | 0.00% | +595,417+63.6% | Added |
| Millennium Management LLC | 1,616,861 | $24.0M | 0.02% | +677,315+72.1% | Added |
| Nuveen Asset Management, LLC | 1,654,672 | $24.5M | 0.01% | +708,780+74.9% | Added |
| Rice Hall James & Associates, LLC | 1,713,825 | $25.4M | 1.45% | −37,082−2.1% | Reduced |
| Susquehanna International Group, LLP | 1,817,000 | $26.9M | 0.04% | +218,070+13.6% | Added |
| Charles Schwab Investment Management Inc | 1,913,100 | $28.4M | 0.01% | +166,077+9.5% | Added |
| Principal Financial Group Inc | 2,005,905 | $29.7M | 0.02% | −630,422−23.9% | Reduced |
| Credit Suisse AG | 2,008,046 | $29.8M | 0.03% | −806,270−28.6% | Reduced |
| Palo Alto Investors LP | 2,112,811 | $31.3M | 3.53% | +6,019+0.3% | Added |
| MPM Oncology Impact Management LP | 2,200,000 | $32.6M | 5.24% | −1,089,470−33.1% | Reduced |
| Northern Trust Corp | 2,227,344 | $33.0M | 0.01% | +44,467+2.0% | Added |
| D. E. Shaw & Co., Inc. | 2,352,166 | $34.9M | 0.04% | +2,137,032+993.3% | Added |
| Hood River Capital Management LLC | 2,624,238 | $38.9M | 0.87% | +622,728+31.1% | Added |
| Morgan Stanley | 2,691,021 | $39.9M | 0.00% | −1,024,524−27.6% | Reduced |
| Dimensional Fund Advisors LP | 2,871,498 | $42.6M | 0.01% | −645,489−18.4% | Reduced |
| Summit Partners Public Asset Management, LLC | 2,965,987 | $44.0M | 2.10% | +2,965,987 | New |
| Pictet Asset Management Holding SA | 3,250,554 | $47.5M | 0.05% | −2,012,755−38.2% | Reduced |
| Voloridge Investment Management, LLC | 3,494,184 | $51.8M | 0.19% | +2,511,104+255.4% | Added |
| Soleus Capital Management, L.P. | 3,505,000 | $51.9M | 4.56% | +2,950,000+531.5% | Added |
| Goldman Sachs Group Inc | 3,782,563 | $56.1M | 0.01% | +101,003+2.7% | Added |
| JPMorgan Chase & Co | 4,385,694 | $65.0M | 0.01% | +1,546,027+54.4% | Added |
| Artisan Partners Limited Partnership | 5,138,222 | $76.1M | 0.11% | +310,552+6.4% | Added |
| Price T Rowe Associates Inc | 5,267,864 | $78.1M | 0.01% | +1,991,262+60.8% | Added |
| Geode Capital Management, LLC | 5,506,617 | $81.6M | 0.01% | +469,519+9.3% | Added |
| State Street Corp | 10,402,719 | $154.2M | 0.01% | −6,021,669−36.7% | Reduced |
| Avoro Capital Advisors LLC | 11,700,000 | $173.4M | 2.02% | +5,000,000+74.6% | Added |
| Perceptive Advisors LLC | 19,272,991 | $285.6M | 5.03% | +7,293,576+60.9% | Added |
| BlackRock Inc. | 19,929,702 | $295.4M | 0.01% | +857,946+4.5% | Added |
| MHR Fund Management LLC | 23,997,103 | $355.6M | 34.36% | +4,000,000+20.0% | Added |
| Vanguard Group Inc | 24,915,300 | $369.2M | 0.01% | +2,102,480+9.2% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −4,707,458−100.0% | Sold out |
| Invenomic Capital Management LP | 0 | $0 | 0.00% | −1,053,251−100.0% | Sold out |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −677,350−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −655,057−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −637,742−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −468,821−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −198,800−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −138,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −104,059−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −56,959−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −31,494−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −22,712−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −21,270−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −20,785−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,149−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −17,400−100.0% | Sold out |
| Keystone Financial Group | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −14,999−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −13,266−100.0% | Sold out |
| Calton & Associates, Inc. | 0 | $0 | 0.00% | −12,090−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −11,977−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −11,703−100.0% | Sold out |
| Dumont & Blake Investment Advisors LLC | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Bank Pictet & Cie (Asia) Ltd | 0 | $0 | 0.00% | −11,227−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |